Lin J, Lingohr-Smith M, & Fan T. (2016). Real-world medication persistence and outcomes associated with basal insulin and glucagon-like peptide 1 receptor agonist free-dose combination therapy in patients with type 2 diabetes in the US. Dove Medical Press.
Chicago Style (17th ed.) CitationLin J, Lingohr-Smith M, and Fan T. Real-world Medication Persistence and Outcomes Associated with Basal Insulin and Glucagon-like Peptide 1 Receptor Agonist Free-dose Combination Therapy in Patients with Type 2 Diabetes in the US. Dove Medical Press, 2016.
MLA (9th ed.) CitationLin J, et al. Real-world Medication Persistence and Outcomes Associated with Basal Insulin and Glucagon-like Peptide 1 Receptor Agonist Free-dose Combination Therapy in Patients with Type 2 Diabetes in the US. Dove Medical Press, 2016.